ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10BX02 | G | Repaglinide - 0.5mg | 9235 | 79917/1 | REPAGLINIDE ARROW LAB | 0.5mg | 90 | Tablet | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 831,839 L.L | 23.08 | A2 | Arrow Génériques | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10BX02 | B | Repaglinide - 0.5mg | 2036 | 236884/99 | NOVONORM | 0.5mg | 30 | Tablet | Oral | Mersaco | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 475,720 L.L | 23.08 | A1 | Novo Nordisk AS | Denmark | 2/5/2024 | 0 |